What an Open Data Ecosystem Can Do for Clinical Development

In this webinar, we discussed recent progress in clinical development, particularly given the FDA’s push to incorporate real world data for protocol feasibility analysis, hybrid trial design, patient recruitment, and running post-marketing surveillance studies. We explained why an open data ecosystem is essential for those efforts – that is, a data ecosystem where parties can bilaterally exchange and connect data for a variety of use cases while complying with regulations and protecting individual patient privacy; and we discussed some of the work that Parexel and Datavant are doing together to help accelerate progress in the space.